Skip to main content
BCAX filings

Corporate insider profile

Claire Mazumdar Filing Activity

Latest reported as Chief Executive Officer of Bicara Therapeutics Inc. (BCAX).

Purchase filings
0
Reported companies
1
Net open-market value
-$654,724.50
Latest transaction
May 18, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 18, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale15,000$20.04$300,579
Apr 20, 2026Bicara Therapeutics Inc. (BCAX)Chief Executive OfficerSale15,000$23.61$354,146